Scientists test COVID drug safety in people with liver issues
NCT ID NCT06568861
Summary
This study tested a potential oral medicine for COVID-19, called ALG-097558, to see how it is processed in the body of people with moderate liver problems compared to healthy people. Sixteen participants took the drug twice a day. The main goal was to measure the drug's levels in the blood and check for safety, not to treat COVID-19.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
-
University of Miami
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.